KERNX Health review
The consultation is priced as three named tiers and is charged only when treatment is approved.
The verdict
KERNX Health publishes $209 a month for compounded semaglutide and $299 for tirzepatide. Each is one flat price at every dose. A provider consultation fee of $25 to $60 is charged separately, and only on approval.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Flat across doses
- States
- 50
- From
- From $209/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
KERNX Health sells compounded semaglutide and compounded tirzepatide. Both are weekly injections. The rates read $209 and $299 a month. No membership fee or three-month plan is required. Coverage is published as fifty states.
Who writes the prescription, and what do they see?
The consultation fee is billed apart from the medication rate. It is charged only when treatment is approved. Three tiers are published. A message-based review is $25. A standard live visit is $35. A complex live visit is $60. An applicant who is declined pays none of them.
Care is arranged remotely. Two charges apply rather than one. The medication rate is monthly. The consultation fee is charged at approval. The site states that no membership fee applies. Nothing else was recorded beside either figure.
What happens when the dose goes up?
Both rates are stated as flat at every dose. An escalation does not move the medication charge. The first sixteen weeks are an escalation for most patients. Whether a dose change triggers a further visit fee is not published. A second visit inside that window is therefore possible.
What the price includes
$209 is the semaglutide rate. $299 is the tirzepatide rate. The gap is $90 a month. Neither requires a three-month plan. Add $25 to $60 once, at approval.
What it claims, and what it cites
Both products are compounded. A pharmacy prepares them. No regulator reviews the finished vial. A compounded preparation is not FDA-approved. The published trial results used the approved products at label doses. A compounded vial was not what those trials measured.
Where it holds up, and where it does not
- Strength: Consultation fee published as three tiers
- Strength: Fee charged only on approval
- Strength: Rate flat at every dose
- Limitation: Tirzepatide costs $90 more a month
- Limitation: Visit fee at a dose change is unstated
- Limitation: Consultation billed apart from the rate
What the evidence says about this kind of treatment
The assessment above is about KERNX Health. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who wants the clinician charge stated as a number before intake. Three tiers are published.
- Wrong for
- A reader who wants one charge rather than two. The consultation is billed apart from the rate.
The evidence behind what KERNX Health prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How KERNX Health compares
| Seller | Who it suits | Go |
|---|---|---|
 NextMeds | A reader who wants one charge covering medication and care, at a rate stated to hold from the first order. | See NextMeds → |
 AVARA Rx | A reader who wants the consult inside the price, and who plans against the standing rate rather than a code that can be withdrawn. | See AVARA Rx → |
| EverSlim | A reader who wants one monthly charge covering the medication, the visit and the postage, without a prepay term attached to reach the rate. | See EverSlim → |
More GLP-1 telehealth sellers reviews: MedroMedsol RXMEDViMetaboost RxMevo HealthMidi Health
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Is the consultation fee charged before approval?
- No. KERNX states that it applies only when treatment is approved. A declined applicant pays nothing.
- Is there a membership or a minimum term?
- No. The page states no membership fee and no required three-month plan.
- Does the price rise with the dose?
- No. Both rates are stated as flat at every dose. A dose change may still require a visit, and that visit is priced separately.
- Is KERNX Health expensive compared with other GLP-1 telehealth sellers?
- KERNX Health publishes a starting figure of $209/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts KERNX Health above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.